274 related articles for article (PubMed ID: 35941602)
1. Short-term and long-term outcomes of indocyanine green for sentinel lymph node biopsy in early-stage breast cancer.
Hua B; Li Y; Yang X; Ren X; Lu X
World J Surg Oncol; 2022 Aug; 20(1):253. PubMed ID: 35941602
[TBL] [Abstract][Full Text] [Related]
2. Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study.
Guo J; Yang H; Wang S; Cao Y; Liu M; Xie F; Liu P; Zhou B; Tong F; Cheng L; Liu H; Wang S
World J Surg Oncol; 2017 Nov; 15(1):196. PubMed ID: 29096643
[TBL] [Abstract][Full Text] [Related]
3. Sentinel Lymph Node Mapping in Breast Cancer Patients Through Fluorescent Imaging Using Indocyanine Green: The INFLUENCE Trial.
Bargon CA; Huibers A; Young-Afat DA; Jansen BAM; Borel-Rinkes IHM; Lavalaye J; van Slooten HJ; Verkooijen HM; van Swol CFP; Doeksen A
Ann Surg; 2022 Nov; 276(5):913-920. PubMed ID: 35894448
[TBL] [Abstract][Full Text] [Related]
4. Can Low-cost Indo Cyanine Green Florescence Technique for Sentinel Lymph Node Biopsy Replace Dual Dye (Radio-colloid and Blue Dye) Technique in Early Breast Cancer: A Prospective Two-arm Comparative Study.
Somashekhar SP; Kumar CR; Ashwin KR; Zaveri SS; Jampani A; Ramya Y; Parameswaran R; Rakshit S
Clin Breast Cancer; 2020 Oct; 20(5):e576-e583. PubMed ID: 32389561
[TBL] [Abstract][Full Text] [Related]
5. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
6. Novel Dual Tracer Indocyanine Green and Radioisotope Versus Gold Standard Sentinel Lymph Node Biopsy in Breast Cancer: The GREENORBLUE Trial.
Nguyen CL; Zhou M; Easwaralingam N; Seah JL; Azimi F; Mak C; Pulitano C; Warrier S
Ann Surg Oncol; 2023 Oct; 30(11):6520-6527. PubMed ID: 37402976
[TBL] [Abstract][Full Text] [Related]
7. Indocyanine Green and Methylene Blue Dye Guided Sentinel Lymph Node Biopsy in Early Breast Cancer: A Single-Center Retrospective Survival Study in 1574 Patients.
Yang R; Dong C; Jiang T; Zhang X; Zhang F; Fan Z
Clin Breast Cancer; 2023 Jun; 23(4):408-414. PubMed ID: 36907808
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the indocyanine green dye method versus the combined method of indigo carmine blue dye with indocyanine green fluorescence imaging for sentinel lymph node biopsy in breast conservative therapy for stage ≤IIA breast cancer.
Takemoto N; Koyanagi A; Yasuda M; Yamamoto H
BMC Womens Health; 2018 Sep; 18(1):151. PubMed ID: 30227837
[TBL] [Abstract][Full Text] [Related]
9. Combining Indocyanine Green and Tc
Lührs O; Ekdahl L; Lönnerfors C; Geppert B; Persson J
Gynecol Oncol; 2020 Feb; 156(2):335-340. PubMed ID: 31780237
[TBL] [Abstract][Full Text] [Related]
10. Indocyanine Green Fluorescence Versus Blue Dye or Radioisotope Regarding Detection Rate of Sentinel Lymph Node Biopsy and Nodes Removed in Breast Cancer: A Systematic Review and Meta-Analysis.
Thongvitokomarn S; Polchai N
Asian Pac J Cancer Prev; 2020 May; 21(5):1187-1195. PubMed ID: 32458621
[TBL] [Abstract][Full Text] [Related]
11. Comparing single or dual tracing modality on sentinel lymph node biopsy from patients who plan to omitting axillary lymph node dissection referring to the criteria of Z0011 trial: a retrospective study.
Xu Y; Wu H; Zhang W; Shen Y; Jiang Y; Meng L
Updates Surg; 2022 Jun; 74(3):1073-1078. PubMed ID: 35389176
[TBL] [Abstract][Full Text] [Related]
12. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
Foster D; Choy N; Porter C; Ahmed S; Wapnir I
J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459
[TBL] [Abstract][Full Text] [Related]
13. Indocyanine green fluorescence method for sentinel lymph node biopsy in breast cancer.
Lin J; Lin LS; Chen DR; Lin KJ; Wang YF; Chang YJ
Asian J Surg; 2020 Dec; 43(12):1149-1153. PubMed ID: 32143963
[TBL] [Abstract][Full Text] [Related]
14. Clinical study of combined application of indocyanine green and methylene blue for sentinel lymph node biopsy in breast cancer.
Zhang C; Li Y; Wang X; Zhang M; Jiang W; Ou J
Medicine (Baltimore); 2021 Apr; 100(15):e25365. PubMed ID: 33847634
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of the additional use of blue dye for indocyanine green for sentinel node biopsy in breast cancer.
Ji Y; Luo N; Jiang Y; Li Q; Wei W; Yang H; Liu J
J Surg Res; 2017 Jul; 215():88-92. PubMed ID: 28688667
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node detection by means of indocyanine green using the Karl Storz VITOM
Staubach P; Scharl A; Ignatov A; Ortmann O; Inwald EC; Hildebrandt T; Gerken M; Klinkhammer-Schalke M; Scharl S; Papathemelis T
J Cancer Res Clin Oncol; 2021 Jun; 147(6):1813-1823. PubMed ID: 33230583
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m-indocyanine green versus technetium-99m-methylene blue for sentinel lymph node biopsy in early-stage endometrial cancer.
Cabrera S; Bebia V; Franco-Camps S; Forcada C; Villasboas-Rosciolesi D; Navales I; Pérez-Benavente A; Gil-Moreno A
Int J Gynecol Cancer; 2020 Mar; 30(3):311-317. PubMed ID: 31992599
[TBL] [Abstract][Full Text] [Related]
18. Utilization of Indocyanine Green to Aid in Identifying Sentinel Lymph Nodes in Merkel Cell Cancer.
Knackstedt RW; Knackstedt T; Gastman B
J Surg Res; 2018 Dec; 232():365-368. PubMed ID: 30463742
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of optical imaging combined with indocyanine green-guided sentinel lymph node biopsy in gastric cancer: a meta-analysis].
He MF; Jiang ZW; Hao ZW; An J; Zhai J; Shen JK
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1196-1204. PubMed ID: 31874538
[No Abstract] [Full Text] [Related]
20. Diagnostic Performance of Indocyanine Green Plus Methylene Blue Versus Radioisotope Plus Methylene Blue Dye Method for Sentinel Lymph Node Biopsy in Node-Negative Early Breast Cancer.
Agrawal SK; Hashlamoun I; Karki B; Sharma A; Arun I; Ahmed R
JCO Glob Oncol; 2020 Jul; 6():1225-1231. PubMed ID: 32749861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
